EquipX, a leader in AI-driven equipment management solutions, has partnered with Vizient, the largest healthcare performance improvement company in the U.S., to enhance healthcare equipment procurement and management. This collaboration aims to optimize fleet management, improving efficiency and performance across…
Reprieve Cardiovascular, Inc., a company focused on developing treatments for acute decompensated heart failure (ADHF), announced today the first-in-human results of the Reprieve System at the CSI Focus D-HF (Device therapies in heart failure) conference in Frankfurt, Germany. The study…
Adagio Medical Holdings, Inc. (Nasdaq: ADGM), a leader in catheter ablation technologies for treating cardiac arrhythmias, announced today that founder Olav Bergheim has stepped down as Chief Executive Officer (CEO) and Chairperson of the Board of Directors, effective December 13,…
HistoSonics, the maker of the Edison® Histotripsy System, announced the successful treatment of the first pancreatic tumor patients in its GANNON trial. This feasibility study aims to assess the safety of histotripsy, a cutting-edge non-invasive technology that uses focused ultrasound…
Fluid Biomed Inc., a clinical-stage medical device company focused on developing lifesaving solutions for vascular disease patients, has successfully raised $27 million in an oversubscribed Series A funding round. The financing was co-led by Amplitude Ventures and a major undisclosed…
NeoPhore Limited, a company specializing in small molecule neoantigen immuno-oncology therapies, has appointed Michael Shih as its Chief Executive Officer (CEO) and as a member of the Board of Directors, effective immediately. This appointment marks a significant milestone as the…
Gerresheimer, a leading provider of innovative systems and solutions for the pharma, biotech, and cosmetics industries, announced that the U.S. Food and Drug Administration (FDA) has granted Tentative Approval for SQ Innovation’s Lasix® ONYU. This product is designed for home…
Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading biopharmaceutical provider in China, has announced the initiation of a Phase III clinical trial for its bivalent vaccine candidate, designed to prevent Hand, Foot, and Mouth Disease (HFMD) caused…
True You Weight Loss, the nation’s first dedicated endobariatric weight loss center, has announced two new FDA-authorized clinical trials focused on providing innovative, non-surgical weight loss solutions without relying on GLP-1 medications. These studies expand True You’s portfolio of ten…
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC), a clinical-stage biotherapeutics company, today announced positive results from the Phase 2b ELEVATE IPF trial. The study evaluated deupirfenidone (LYT-100) in patients with idiopathic pulmonary fibrosis (IPF). In this randomized, double-blind, placebo-controlled trial,…
Celltrion announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued positive opinions for three of its biosimilar candidates: Eydenzelt® (CT-P42, aflibercept), Stoboclo® and Osenvelt® (CT-P41, denosumab), and Avtozma® (CT-P47, tocilizumab). These recommendations…
MultiPlan Corporation (NYSE: MPLN), a leading provider of data-driven cost management solutions, has announced the launch of CompleteVue™, an innovative software platform designed to help health systems and healthcare providers gain valuable insights into the healthcare market using publicly available…